C-2-Aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors

Por Hunter, Roger, Younis, Yassir, Muhanji, Clare I., Curtin, Tanith-lea, Naidoo, Kevin J., Petersen, Melissa, Bailey, Christopher M., Basavapathruni, Aravind, Anderson, Karen S.
Publicado em 2008

Envelope Variable Region 4 Is the First Target of Neutralizing Antibodies in Early Simian Immunodeficiency Virus mac251 Infection of Rhesus Monkeys

Por Yeh, Wendy W., Brassard, Laura M., Miller, Caroline A., Basavapathruni, Aravind, Zhang, Jinrong, Rao, Srinivas S., Nabel, Gary J., Mascola, John R., Letvin, Norman L., Seaman, Michael S.
Publicado em 2012

Envelope Vaccination Shapes Viral Envelope Evolution following Simian Immunodeficiency Virus Infection in Rhesus Monkeys

Por Basavapathruni, Aravind, Yeh, Wendy W., Coffey, Rory T., Whitney, James B., Hraber, Peter T., Giri, Ayush, Korber, Bette T., Rao, Srinivas S., Nabel, Gary J., Mascola, John R., Seaman, Michael S., Letvin, Norman L.
Publicado em 2010

Bifunctional Inhibition of HIV-1 Reverse Transcriptase: A First Step in Designing a Bifunctional Triphosphate()

Por Piao, Dongyuan, Basavapathruni, Aravind, Iyidogan, Pinar, Dai, Guangxiu, Hinz, Wolfgang, Ray, Adrian S., Murakami, Eisuke, Feng, Joy Y., You, Fei, Dutschman, Ginger E., Austin, David J., Parker, Kathlyn A., Anderson, Karen S.
Publicado em 2012

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia

Por Daigle, Scott R., Olhava, Edward J., Therkelsen, Carly A., Basavapathruni, Aravind, Jin, Lei, Boriack-Sjodin, P. Ann, Allain, Christina J., Klaus, Christine R., Raimondi, Alejandra, Scott, Margaret Porter, Waters, Nigel J., Chesworth, Richard, Moyer, Mikel P., Copeland, Robert A., Richon, Victoria M., Pollock, Roy M.
Publicado em 2013